RORC and neoplasm: It has been demonstrated that the main Th17 cell effector cytokines, IL-17, can up-regulate lymphocyte proliferation and down-regulate immunosuppressive Treg and Th2 cells, finally exerting anti-tumor effects to inhibit tumor growth.[60] The anti-COAD effect of RORC had been demonstrated in several studies.